Announcement of TTY Biopharm's unaudited income information in Feb 2022
· Issued by TTY Biopharm Company Limited
Close
Today's Information
Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO
1
Date of announcement
2022/03/11
Time of announcement
13:38:38
Subject
Announcement of TTY Biopharm's unaudited
income information in Feb 2022
Date of events
2022/03/11
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/03/11
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of
$262,346 thousands(expressed in NT dollars; unaudited), a consolidated
operating profit of $56,564 thousands, and a consolidated income
before tax of $61,113 thousands in Feb 2022; net income attributed to
stockholders of the company was $49,498 thousands; EPS is $0.2.
Year-to-date consolidated net sales was $669,873 thousands (in NT
dollars; unaudited), a consolidated operating profit was $165,439
thousands and consolidated income before tax was $177,843 thousands
until Feb 2022; year-to-date net income attributed to stockholders
of the company was $139,185 thousands; EPS is $0.56.
6.Countermeasures:None.
7.Any other matters that need to be specified:The numbers above are unaudited.
In term of the final net sales and profits, quarterly financial reports
audited by independent accountants will prevail.
